Kazutaka Sumita Selected Research

Phosphotransferases (Kinase)

1/2016	The Lipid Kinase PI5P4Kβ Is an Intracellular GTP Sensor for Metabolism and Tumorigenesis.
1/2013	A homogeneous, high-throughput assay for phosphatidylinositol 5-phosphate 4-kinase with a novel, rapid substrate preparation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazutaka Sumita Research Topics

Disease

9	Neoplasms (Cancer) 04/2024 - 01/2013
5	Stroke (Strokes) 12/2023 - 01/2021
5	Ischemic Stroke 01/2023 - 01/2021
3	Intracranial Aneurysm (Cerebral Aneurysm) 11/2023 - 06/2023
2	Glioblastoma (Glioblastoma Multiforme) 10/2023 - 01/2019
2	COVID-19 01/2023 - 01/2021
2	Hemorrhage 09/2022 - 10/2018
2	Pathologic Constriction (Stenosis) 04/2022 - 01/2021
2	Carcinogenesis 01/2019 - 01/2016
1	Hydrocephalus (Hydrocephaly) 01/2024
1	Embolism (Embolus) 01/2024
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2024
1	Infarction (Infarctions) 03/2023
1	Central Nervous System Vascular Malformations (Dural Arteriovenous Fistula) 01/2023
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2023
1	Headache (Headaches) 01/2023
1	Blood Vessel Dissection 01/2023
1	Vascular Diseases (Vascular Disease) 09/2022
1	Hypersensitivity (Allergy) 04/2022
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 04/2022
1	Paresis (Hemiparesis) 04/2022
1	Aneurysm (Aneurysms) 04/2022
1	Infections 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Vision Disorders (Hemeralopia) 01/2021
1	Chordoma 07/2020
1	Cysts 07/2020
1	Trigeminal Neuralgia (Tic Douloureux) 11/2019
1	Hypertrophy 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	False Aneurysm (Pseudoaneurysm) 10/2018
1	Oligodendroglioma 06/2018
1	Radiation induced meningioma 06/2018
1	Glioma (Gliomas) 01/2017

Drug/Important Bio-Agent (IBA)

3	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2024 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2017
2	EnzymesIBA 10/2023 - 01/2019
2	GadoliniumIBA 07/2021 - 07/2020
2	Phosphotransferases (Kinase)IBA 01/2016 - 01/2013
2	Guanosine Triphosphate (GTP)IBA 01/2016 - 02/2014
1	Dihydrotachysterol (AT 10)IBA 12/2023
1	phosphatidylinositol 5-phosphateIBA 10/2023
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 06/2023
1	AnticoagulantsIBA 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2023
1	VaccinesIBA 01/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2022
1	Clopidogrel (Plavix)FDA Link 09/2022
1	MetalsIBA 04/2022
1	CobaltIBA 04/2022
1	Cytidine Triphosphate (CTP)IBA 01/2022
1	Methionine (L-Methionine)FDA Link 07/2021
1	Acetazolamide (Diamox)FDA LinkGeneric 01/2021
1	Transfer RNA (tRNA)IBA 01/2019
1	Inosine Monophosphate (IMP)IBA 01/2019
1	Guanine NucleotidesIBA 01/2019
1	Factor VIII (Coagulation Factor VIII)IBA 01/2017
1	LipidsIBA 01/2016

Therapy/Procedure

7	Therapeutics 10/2023 - 01/2021
6	Stents 01/2024 - 01/2021
3	Thrombectomy 01/2023 - 01/2021
1	Embolic Protection Devices 01/2024
1	Punctures 08/2022
1	N95 Respirators 01/2021
1	Catheters 01/2021
1	Personal Protective Equipment 01/2021
1	Microvascular Decompression Surgery 11/2019
1	Dentures 10/2018
1	Radiotherapy 06/2018